KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Current Taxes (2016 - 2025)

Historic Current Taxes for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $4.8 billion.

  • Merck's Current Taxes rose 1196.3% to $4.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 1196.3%. This contributed to the annual value of $3.9 billion for FY2024, which is 4775.39% up from last year.
  • Per Merck's latest filing, its Current Taxes stood at $4.8 billion for Q3 2025, which was up 1196.3% from $4.2 billion recorded in Q2 2025.
  • Merck's 5-year Current Taxes high stood at $5.2 billion for Q1 2025, and its period low was $954.0 million during Q3 2021.
  • For the 5-year period, Merck's Current Taxes averaged around $2.5 billion, with its median value being $2.0 billion (2023).
  • Per our database at Business Quant, Merck's Current Taxes tumbled by 2335.63% in 2021 and then surged by 11857.65% in 2024.
  • Quarter analysis of 5 years shows Merck's Current Taxes stood at $1.2 billion in 2021, then skyrocketed by 62.25% to $2.0 billion in 2022, then skyrocketed by 33.38% to $2.6 billion in 2023, then skyrocketed by 47.75% to $3.9 billion in 2024, then rose by 23.86% to $4.8 billion in 2025.
  • Its Current Taxes stands at $4.8 billion for Q3 2025, versus $4.2 billion for Q2 2025 and $5.2 billion for Q1 2025.